List of Provigil drug patents

Provigil is owned by Cephalon.

Provigil contains Modafinil.

Provigil has a total of 2 drug patents out of which 0 drug patents have expired.

Provigil was authorised for market use on 24 December, 1998.

Provigil is available in tablet;oral dosage forms.

The generics of Provigil are possible to be released after 29 May, 2024.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297346 CEPHALON Pharmaceutical formulations of modafinil
Nov, 2023

(10 months from now)

US7297346

(Pediatric)

CEPHALON Pharmaceutical formulations of modafinil
May, 2024

(1 year, 4 months from now)

Drugs and Companies using MODAFINIL ingredient

Market Authorisation Date: 24 December, 1998

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of PROVIGIL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in